In Vivo MicroRNA-155 Expression Influences Antigen-specific T Cell-mediated Immune Responses Generated by DNA Vaccination
Overview
Authors
Affiliations
Background: MicroRNA (miRNA) molecules are potent mediators of post-transcriptional gene silencing that are emerging to be critical in the regulation of innate and adaptive immunity.
Results: Here we report that miR-155--an oncogenic miRNA with important function in the mammalian immune system--is induced in dendritic cells (DCs) upon maturation and potentially attenuates their ability to activate T cells. Biolistic epidermal transfection with DNA encoding miR-155 suppressed the induction of antigen-specific T cell-mediated immunity, whereas reduction of endogenous miR-155 by a partially complementary antisense sequence reversed this effect. Because DCs represent a significant component of epidermal tissue and are among the most potent of antigen-presenting cells, the inhibitory actions of miR-155 could be mediated through this subset of cells.
Conclusions: These results suggest that miR-155 may repress the expression of key molecules involved in lymph node migration, antigen presentation, or T cell activation in DCs, and thus forms part of a negative regulatory pathway that dampens the generation of T cell-mediated immune responses. Modulation of miR-155 expression in epidermis therefore represents a potentially promising form of gene therapy for the control of diseases ranging from autoimmunity to cancer and viral infection.
Functional Role of miR-155 in the Pathogenesis of Diabetes Mellitus and Its Complications.
Jankauskas S, Gambardella J, Sardu C, Lombardi A, Santulli G Noncoding RNA. 2021; 7(3).
PMID: 34287359 PMC: 8293470. DOI: 10.3390/ncrna7030039.
Fiorentina P, Martino C, Mancini Y, De Iorio M, Williams J, Minozzi G Animals (Basel). 2021; 11(7).
PMID: 34199073 PMC: 8300312. DOI: 10.3390/ani11071912.
Embryonic extracellular vesicles as informers to the immune cells at the maternal-fetal interface.
Giacomini E, Alleva E, Fornelli G, Quartucci A, Privitera L, Vanni V Clin Exp Immunol. 2019; 198(1):15-23.
PMID: 31009068 PMC: 6718282. DOI: 10.1111/cei.13304.
McCormick S, Heller N Front Immunol. 2015; 6:549.
PMID: 26579124 PMC: 4621458. DOI: 10.3389/fimmu.2015.00549.
Weng W, Feng J, Qin H, Ma Y, Goel A Future Oncol. 2015; 11(12):1791-808.
PMID: 26075447 PMC: 4489702. DOI: 10.2217/fon.15.83.